| Cancer risk in families with hereditary nonpolyposis colorectal cancer diagnosed by mutation analysis HF Vasen, JT Wijnen, FH Menko, JH Kleibeuker, BG Taal, G Griffioen, ... Gastroenterology 110 (4), 1020-1027, 1996 | 1065 | 1996 |
| Frequency and spectrum of cancers in the Peutz-Jeghers syndrome N Hearle, V Schumacher, FH Menko, S Olschwang, LA Boardman, ... Clinical Cancer Research 12 (10), 3209-3215, 2006 | 1048 | 2006 |
| Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer JMJ Piek, PJ Van Diest, RP Zweemer, JW Jansen, RJJ Poort‐Keesom, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2001 | 991 | 2001 |
| Birt-Hogg-Dubé syndrome: diagnosis and management FH Menko, MAM Van Steensel, S Giraud, L Friis-Hansen, S Richard, ... The lancet oncology 10 (12), 1199-1206, 2009 | 635 | 2009 |
| Cancer risk in hereditary nonpolyposis colorectal cancer due to MSH6 mutations: impact on counseling and surveillance YMC Hendriks, A Wagner, H Morreau, F Menko, A Stormorken, ... Gastroenterology 127 (1), 17-25, 2004 | 513 | 2004 |
| Cancer risks in BRCA2 families: estimates for sites other than breast and ovary CJ Van Asperen, RM Brohet, EJ Meijers-Heijboer, N Hoogerbrugge, ... Journal of medical genetics 42 (9), 711-719, 2005 | 508 | 2005 |
| Familial endometrial cancer in female carriers of MSH6 germline mutations J Wijnen, W Leeuw, H Vasen, H Klift, P Møller, A Stormorken, ... Nature genetics 23 (2), 142-144, 1999 | 493 | 1999 |
| MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: a study of hereditary nonpolyposis colorectal cancer families. HF Vasen, A Stormorken, FH Menko, FM Nagengast, JH Kleibeuker, ... | 491 | 2001 |
| Clinical findings with implications for genetic testing in families with clustering of colorectal cancer JT Wijnen, HFA Vasen, PM Khan, AH Zwinderman, H van der Klift, ... New England Journal of Medicine 339 (8), 511-518, 1998 | 491 | 1998 |
| Large genomic deletions and duplications in the BRCA1 gene identified by a novel quantitative method FBL Hogervorst, PM Nederlof, JJP Gille, CJ McElgunn, M Grippeling, ... Cancer research 63 (7), 1449-1453, 2003 | 411 | 2003 |
| Rapid detection of BRCA1 mutations by the protein truncation test FBL Hogervorst, RS Cornelis, M Bout, M Vliet, JC Oosterwijk, R Olmer, ... Nature genetics 10 (2), 208-212, 1995 | 409 | 1995 |
| TP53 germline mutation testing in 180 families suspected of Li–Fraumeni syndrome: mutation detection rate and relative frequency of cancers in different familial phenotypes MWG Ruijs, S Verhoef, MA Rookus, R Pruntel, AH van der Hout, ... Journal of medical genetics 47 (6), 421-428, 2010 | 360 | 2010 |
| Risks of less common cancers in proven mutation carriers with lynch syndrome C Engel, M Loeffler, V Steinke, N Rahner, E Holinski-Feder, W Dietmaier, ... Journal of Clinical Oncology 30 (35), 4409-4415, 2012 | 343 | 2012 |
| Hereditary leiomyomatosis and renal cell cancer (HLRCC): renal cancer risk, surveillance and treatment FH Menko, ER Maher, LS Schmidt, LA Middelton, K Aittomäki, I Tomlinson, ... Familial cancer 13, 637-644, 2014 | 327 | 2014 |
| Relative frequency and morphology of cancers in STK11 mutation carriers W Lim, S Olschwang, JJ Keller, AM Westerman, FH Menko, LA Boardman, ... Gastroenterology 126 (7), 1788-1794, 2004 | 323 | 2004 |
| Familial hypocalciuric hypercalcemia and neonatal severe hyperparathyroidism. Effects of mutant gene dosage on phenotype. MR Pollak, YH Chou, SJ Marx, B Steinmann, DE Cole, ML Brandi, ... The Journal of clinical investigation 93 (3), 1108-1112, 1994 | 299 | 1994 |
| MSH2 genomic deletions are a frequent cause of HNPCC J Wijnen, H van der Klift, H Vasen, PM Khan, F Menko, C Tops, ... Nature genetics 20 (4), 326-328, 1998 | 267 | 1998 |
| The role of mismatch repair gene defects in the development of adenomas in patients with HNPCC AE De Jong, H Morreau, M Van Puijenbroek, PHC Eilers, J Wijnen, ... Gastroenterology 126 (1), 42-48, 2004 | 240 | 2004 |
| Molecular evidence linking primary cancer of the fallopian tube to BRCA1 germline mutations RP Zweemer, PJ Van Diest, RHM Verheijen, A Ryan, JJP Gille, ... Gynecologic oncology 76 (1), 45-50, 2000 | 228 | 2000 |
| Lynch Syndrome Caused by Germline PMS2 Mutations: Delineating the Cancer Risk SW Ten Broeke, RM Brohet, CM Tops, HM van der Klift, ME Velthuizen, ... Journal of Clinical Oncology 33 (4), 319-325, 2015 | 223 | 2015 |
